Abstract
Regenerative medicine by directed differentiation of embryonic stem cells (ESCs) involves a therapeutic cloning procedure in which pluripotent cells are isolated from the inner cell mass (ICM) of blastocysts generated by somatic cell nuclear transfer. However, our prior experiments have shown that the development of such cloned embryo is impaired. It is not clear whether the efficiency of ESC derivation from cloned embryos is also compromised and whether there is any influence of the source of somatic cell nuclei.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
